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ABSTRACT
Chemopreventive Effects of Curcumin and Green Tea on
B[a]P-induced Carcinogenesis in the Hamster Cheek Pouch.  (May 2005)
Jimi Lynn Brandon, B.S., Texas State University
Co-Chairs of Advisory Committee:  Dr. George Stoica
                  Dr. Irma Gimenez-Conti
The present study was carried out to examine the chemopreventive effects of
curcumin and green tea polyphenols on the hamster cheek pouch carcinogenesis model.
This model of oral carcinogenesis has been widely used in chemoprevention studies,
however, these studies have been limited to the use of DMBA as the carcinogenic
agent.  We have developed a protocol of carcinogenesis in the hamster cheek pouch
using B[a]P, a broadly distributed environmental carcinogen, formed as a by-product of
the combustion of organic materials including cigarette smoke.  B[a]P- induced tumors
in the hamster cheek pouch are primarily endophytic squamous cell carcinomas that
closely resemble squamous cell carcinomas of the human oral mucosa.  The cheek
pouch of male Syrian hamsters were treated topically for eight weeks with 0.6%
curcumin, 6.0% curcumin, 2.5% green tea polyphenols, or 5.0% green tea polyphenols,
3 times per week 30 minutes prior to the application of 2.0% B[a]P.
The animals were sacrificed 24 hours and 72 hours after the last treatments.
Short-term mechanistic markers of malignant progression were used to determine
effects of each compound. Cellular proliferation, assessed by bromodeoxyuridine
(Brdu) incorporation, p53 protein accumulation, and apoptotic activity were evaluated.
The results of the present study demonstrated that 0.6% curcumin and 2.5% green tea
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polyphenols had strong inhibitory effects on cellular proliferation and p53 protein
accumulation. And 6.0% curcumin and 5.0% green tea polyphenols appeared to induce
apoptosis.  Our data suggest that curcumin and green tea polyphenols may have a
plausible chemopreventive effect on oral carcinogenesis in the hamster cheek pouch
model.
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1INTRODUCTION
Oral Squamous Cell Carcinoma
Oral cancer is the sixth most common cancer in the world [1], and continues to
be a growing problem.  Oral cancer is considered to be a subdivision of head and neck
cancer, and includes cancers of the lips, tongue, salivary glands, gum, mouth, pharynx,
oropharynx, and hypopharynx.  In the year 2002, there were almost 30,000 new cases of
oral cancer reported in the United States, and 7,400 oral cancer related deaths [2]
(http://seer.cancer.gov/csr/1975-2001/) with similar estimates for 2004. One of the most
astounding statistics is a 56% 5-year survival rate in oral cancer patients[2]. Over the last
several decades the incidence of many cancers has been declining and their prognoses
have been improving. Unfortunately, oral cancer has remained steady during this period,
and has recently begun to increase in the young male population.  Incidence rates for
oral cancer are two to four times higher among men than women [2].  In the past, oral
cancer has primarily affected middle and older-aged individuals but the effected ages are
decreasing, primarily because of the increased use of smokeless tobacco among young
men.  Approximately 11% of high school male students in the United States use
smokeless tobacco [3], and 5.6% of middle school male students in the United States
currently use smokeless tobacco [4].  According to the United States Department of
Agriculture, the output of snuff, a smokeless tobacco put between the labia oris (bottom)
_____________
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2lip) and the mandibular gingiva or the buccal mucosa, has risen over 26% in the past 10
years, from 59.1 million pounds in 1993 to 74.7 million pounds in 2003 [5].  These
increases have recently led us to the importance of studying and developing new
chemoprevention approaches in oral cancer. There are many factors that may contribute
to this disease, but of these the most popular are the use of tobacco products, excessive
alcohol consumption, and a poor, unbalanced diet.  All forms of tobacco use, including
smoking and smokeless tobaccos, have been linked to oral squamous cell carcinoma.  Of
all etiologic factors of oral cancer tobacco is regarded as the most important [6].
Excessive alcohol consumption is also problematic.  Alcohol is not considered a
carcinogen but when used excessively it can permeablize cellular membranes allowing
carcinogens from tobacco and smoke to enter the cell resulting in damage to cellular
structures as well as to the DNA [7-10].  It may also activate the enzymatic machinery
that, in turn, activates carcinogens found in the environment [7].
Approximately 90% of oral cancers are squamous cell carcinomas. The
development of squamous cell carcinomas is a multiple step process.  As in all cancers
oncogenes must be activated and tumor suppressor genes must be inactivated.  These
genetic alterations are often due to chronic exposure to carcinogens, promoters, and
irritants. The lack of regulatory mechanisms due to the genetic alterations of oncogenes
and tumor suppressor genes leads to dysfunction of the homeostatic mechanisms such as
increased proliferation and/or decreased apoptosis and differentiation.  As genetically
altered cells proliferate they form premalignant foci in which the altered cells are
confined by the basement membrane of the dermis.  Eventually the foci can become
3larger and acquire the ability to break through the basement membrane, invade adjacent
tissues, and even metastasize to different parts of the body.
One of the earliest signs of oral carcinogenesis is leukoplakia, a white
precancerous lesion found in the oral cavity that can often progress into squamous cell
carcinoma. Leukoplakia is associated with continuous use of smokeless tobacco.
Clinically it is a white lesion in the oral mucosa.  Histopathologically, the lesion has
hyperkeratosis, hyperplasia and stromal inflammation.  More chronic lesions often have
dysplastic changes [6].  Erythroplakia, a red precancerous lesion, is reported to have an
even higher risk of progression [11].  Histologically, erythroplakia are similar to
leukoplakia but are more dysplastic and vascularized.  Most precancerous lesions are
reversible if exposure to the tobacco products is ceased and lesions are treated early,
however, some of these lesions will continue to progress into squamous cell carcinomas.
Because it is unknown which of these lesions will transform it is of great importance to
research and identify early biomarkers of progression to be used to determine cellular
growth rates, death rates, and genetic damage or alterations.  These biomarkers could
further assist in determining prognosis and treatment.
Oral cancers can be categorized by way of their effected tissues.  Carcinomas of
the lips account for 25-30% of all oral cancers [6].  Carcinomas of the lower lip are more
common than those of the upper lip.  In addition, they seem to grow slower and have a
better prognosis than lesions of the upper lip [6]. Poorly differentiated lesions can
metastasize to local lymph nodes [6].  Squamous cell carcinoma of the tongue is the
most common oral malignancy accounting for 25-40% of all intraoral (excluding lips)
4malignancies [6].  These lesions are more asymptomatic and when finally diagnosed
have usually metastasized to lymph nodes in the neck, and occasionally to the lung or
the liver.  Lesions can also develop on the floor of the mouth.  These squamous cell
carcinomas account for 15-20% of intraoral lesions.  Metastasis often occurs to the
submandibular lymph nodes [6].  Approximately 10% of oral squamous cell carcinomas
develop in the buccal mucosa and gingiva.  The lesions are usually slow growing, well
differentiated and rarely metastasize resulting in a good prognosis [6].  Squamous cell
carcinoma of the soft palate accounts for 10-20% of intraoral lesions.  Metastasis often
occurs to the cervical lymph nodes leading to an extremely poor survival rate, dropping
from 50% to 20% [6]. Most oral squamous cell carcinomas are well differentiated
producing keratin pearls, and invasion may occur into the subjacent structures.  Some
variations between tumors include the number of mitosis, nuclear pleomorphism, and
keratinization.  Poorly differentiated lesions often have lesser amounts of keratin and are
of greater health concerns [6].
Grading of tumors is determined by differentiation of the tumor cells.  Well
differentiated lesions are often less aggressive grading a lower score while poorly
differentiated lesions are more aggressive. All diagnosed oral cancers must be staged to
determine treatment and prognosis.  Staging of cancer is done according to the
International Union Against Cancer (UICC) classification system for oral cancer [12].
Each parameter is evaluated and categorized.  Using these parameters tumors are staged
accordingly:
5*Tumor
T1=Tumor less than 2 centimeters in diameter
T2=Tumor 2-4 centimeters in diameter
T3=Tumor greater than 4 centimeters in diameter
T4=Tumor invades adjacent structures
*Nodes
N0=No palpable nodes
N1=Ipsilateral palpable nodes
N2=Contralateral or bilateral nodes
N3=Fixed palpable nodes
*Metastasis
M0=No distant metastasis
M1=Clinical or radiographic evidence of metastasis
Stage I - T1 N0 M0
Stage II - T2 N0 M0
Stage III - T3 N0, T1-3 N1, and M0
Stage IV - T4 and N, T1-3 N2-3, any T any N M1
The first strategy to reducing this cancer is for all humans to stop excessive use
of tobacco and alcohol, however, that is not always the most realistic solution, therefore
the development of new strategies to prevent these cancers from emerging is of the
utmost importance now and in the future.
6Hamster Cheek Pouch
In 1919, Chinese hamsters were introduced into medical research.  However, by
1930, the hamsters became unsatisfactory because they would not breed in captivity.
Researchers decided to go to Syria to capture native hamsters to take back to their labs.
One mother and ten young were captured.  Nine of the young made it back to the
University.  Five of these eventually gnawed their way out of their cages leaving the
researchers with only four offspring.  These four animals proved to be very prolific, and
soon Syrian (Golden) hamsters (Cricetus auratus) were being shipped to other countries.
This breed of hamster was soon designated as “the” laboratory hamster.  It is a
convenient size, it is very adaptable to laboratory conditions and it has a gentle
disposition [13].
The pouch of the Syrian hamster is located subcutaneous on each lateral side of
the head and neck.  The pouches are muscular sacs that open from the mouth and extend
toward the shoulder.  They measure approximately 35-40 millimeters in length and are
4-8 millimeters wide when empty.  When full of food they can measure up to 20
millimeters wide [13].  These pouches have been used for decades to study the
development of oral squamous cell carcinomas.  In 1954, Salley began producing
squamous cell carcinomas in the cheek pouch [14].  In 1961, Morris standardized
conditions to produce oral squamous cell carcinomas in the hamster cheek pouch using
7,12-dimethylbenz[a]anthracene (DMBA) as the carcinogen [15].  In years to follow,
other researchers have continued studying chemically induced carcinogenesis in this
model and have conducted numerous chemoprevention studies [16-20].
7Benzo[a]Pyrene
Benzo[a]pyrene (B[a]P), a member of the polycyclic aromatic hydrocarbon
(PAH) family, is a Class 2A carcinogen and is widely distributed throughout the world’s
environment.  According to the IARC Carcinogen Classification a class 2A carcinogen
shows adequate evidence of carcinogenicity in experimental animals but limited
evidence of this in humans; however, there is strong evidence that the mechanisms of
carcinogenesis which function in experimental animals also operate in humans.  B[a]P is
formed as a by-product of the combustion of organic materials [21].  B[a]P has been
found in the air, water, soil, food supply, and in cigarette smoke [22].  Although most
studies have successfully used DMBA as the carcinogen in the cheek pouch it is not
environmentally relevant.  Benzo[a]pyrene had been used by Salley in the mid 1950’s
but he found it to be a weak carcinogen [14].  Solt tried several carcinogens in 1987
including B[a]P, however, after 40 weeks of 0.5% B[a]P treatment there were no lesions
[23].  The B[a]P doses used by Salley and Solt were the same doses used for DMBA
treatments.  More recently, Ashurst produced tumors in mouse skin using higher doses
of B[a]P.  The doses were increased approximately 100 times that of the typical DMBA
dose [24].  Using this information, Gimenez-Conti developed a protocol to produce
squamous cell carcinomas in the hamster cheek pouch using B[a]P as the carcinogen
(Brandon, Gimenez-Conti, in progress).  Using 2% B[a]P and a complete carcinogenesis
protocol, diagrammed in Figure 1, pre-malignant lesions are produced at 16 weeks and
squamous cell carcinomas at 20 weeks.  Figure 2 shows an inverted normal cheek pouch.
8It is thin, transparent tissue with the muscle collecting in the center of the pouch.  Figure
3 is an inverted cheek pouch treated with 2% B[a]P for 32 weeks.  Notice the increased
tissue density and the three obvious lesions shown by the arrows.  Figures 4a and 4b are
two premalignant lesions produced by 20 weeks of 2% B[a]P treatment.  These lesions
show hyperkeratosis, hyperplasia, and dysplasia.  In human, many of these lesions are
reversible.  Figure 5 is a carcinoma in situ produced after 32 weeks of 2% B[a]P
treatment.  It appears very similar to a squamous cell carcinoma but the basement
membrane has not yet been penetrated.  This lesion is irreversible.  Figure 6 is a
squamous cell carcinoma in the hamster cheek pouch which was produced after 32
weeks of 2% B[a]P treatment.  The microinvasions into the connective tissue, the
displaced keratin pearls throughout the lesion, the dysplasia and anaplasia, as well as the
multiple mitotic cells are diagnostic markers used to analyze squamous cell carcinomas.
The results of these previous studies have established B[a]P as an applicable carcinogen
for further developmental and chemoprevention studies with the hamster cheek pouch
model.
     Figure 1.  Complete carcinogenesis protocol.  Induction and progression of oral
     squamous cell carcinomas in the hamster cheek pouch using 2% B[a]P suspended in
     mineral oil and a complete carcinogenesis protocol.
Complete Carcinogenesis Protocol
2% B[a]P               
   Week 1 2 3    8      16       20         32
    Premalignant lesions
      Squamous cell carcinomas
9   Figure 2.  Inverted normal cheek pouch.
   Figure 3.  Inverted B[a]P cheek pouch.  Cheek pouch
        treated with 2% B[a]P for 32 weeks.
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     a.
     
     b.
 
     Figure 4.  Histopathology of premalignant lesions.
     Histopathology (a. and b.) of premalignant oral lesions
     in the hamster cheek pouch treated with 2% B[a]P for
          20 weeks (20X).
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     Figure 5.  Histopathology of carcinoma in situ.
     Carcinoma in situ in the hamster cheek pouch
     treated with 2% B[a]P for 32 weeks (10X).
      Figure 6.  Histopathology of squamous cell carcinoma.
      Squamous cell carcinoma of the hamster cheek pouch
            treated with 2% B[a]P for 32 weeks (10X).
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Chemoprevention
Chemoprevention is defined as the systemic use of natural or synthetic agents to
reverse or even suppress the progression of a premalignant lesion [25]. As many as 500
agents have been recognized as possible chemopreventive agents [26].  According to
Linger there are three approaches to oral cancer prevention:  1.  patient education, 2.
early clinical detection of premalignant lesions, and  3.  the use of chemopreventive
agents [27]. Many known chemopreventive compounds are abundant, inexpensive and
easily accessible.  They are often used around the world as every day dietary ingredients.
Two very important aspects to look for when searching for chemopreventive compounds
is to find natural or synthetic agents that will have minimal toxic side effects and that
can be easily taken by people at high risk for malignancies.  However, the use of many
of these compounds has been hampered due to toxic side effects after long-term
exposure or because of high doses.
When studying oral cancer it is of particular importance that these compounds be
able to stop the growth and transformation of premalignant lesions such as leukoplakia
from progressing into squamous cell carcinomas. Most chemopreventive agents can be
divided into three categories depending on their point of inhibition:  compounds
preventing formation of carcinogen from precursor compounds, blocking agents, or
suppressing agents.  The first category describes the compounds that may inhibit
initiation.  Blocking agents function as a barrier preventing a carcinogen from interacting
with the target tissue.  Suppressing agents act to prevent the formation of neoplasia after
a cell has been exposed to a carcinogen [28].  Some chemopreventive agents fit in more
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than one of these categories. The two compounds chosen for this study, curcumin and
green tea polyphenols, can prevent initiation or prevent the formation of carcinogens,
and they both have been found to suppress developing neoplasms. Effective compounds
like these are often inexpensive, show minimal toxicity, have easy treatment protocols,
and are abundant worldwide.  These compounds could lead to strategies necessary to
derive ways to disrupt, regress, and prevent carcinogenesis from occurring.
Green Tea
Other than water, tea is the most widely consumed beverage in the world.
500,000 metric tons of dried green tea are manufactured every year. Green tea and black
tea are made from the same raw tea leaves (Camellia sinensis).  The manufacturing
technology is what differentiates the two.  The manufacturing of green tea limits the
oxidative processes.  Any oxidative transformations deteriorate quality of the tea [29].
Green tea is made by roasting or steaming fresh tea leaves in such a way that the
chemical composition changes minimally.  The tea is then sweated to achieve
tenderness, and rolled.  It is then dried to remove moisture, and rolled again to crush the
leaf blades and stalks.  The tea is cooled and sifted to prepare for firing.  Firing the tea
decreases the moisture content to 3-5% so the tea can then be sorted and packaged [29].
This process limits chemical transformations and only reduces the polyphenols and
catechins by a minimal 17-18% [29].  Listed in Table I are some of the major
components that make up dried green tea leaves.
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        Table I.  Composition of green
        tea leaf [30]
Polyphenols 36.0%
Carbohydrates 25.0%
Protein 15.0%
Lignin 6.50%
Ash 5.0%
Amino Acids 4.0%
Methyl xanthines 3.50%
Lipids 2.0%
Organic Acids 1.50%
Chlorophyll 0.50%
Carotenoids <0.10%
Volatiles <0.10%
Catechins comprise approximately 30% of the weight of extract solids of
manufactured green tea, this compared to 3-10% of the weight of extract solids of
manufactured black tea.  These catechins are believed to have anti-oxidation properties,
antimicrobial properties, and anti-carcinogenic properties.  Table II lists the isolated
catechins found in the fresh tea leaf.
       Table II. Principal leaf catechins.  Principal leaf
       catechins measured in % dry weight [30].
(+) Catechin 1-2%
(-) Epicatechin (EC) 1-3%
(-) Epicatechin gallate (ECG) 3-6%
(+) Gallocatechin 1-3%
(-) Epigallocatechin (EGC) 3-6%
(-) Epigallocatechin gallate (EGCG) 7-13%
          Total catechins 16-30%
      
It is believed that the chemopreventive activity of green tea is due to the anti-
oxidative and possible anti-proliferative effects of these catechins [29].  Reactive oxygen
15
species can damage DNA, alter gene expression or affect cell growth and differentiation
[31].  These catechins could bind to the cell inhibiting the generation of reactive oxygen
species [32], or they may scavenge reactive oxygen species, thus, preventing DNA
damage [33].  Other possible mechanisms including anti-pyretic, diuretic, anti-
inflammatory, radioprotective and antihepatotoxic activities [29] [32] have also been
demonstrated. These polyphenols have inhibited skin tumor initiation by interacting with
Benzo[a]pyrene diol epoxide (BPDE), the ultimate cancer causing metabolite of B[a]P,
preventing the formation of DNA adducts and therefore preventing initiation and
tumorigenesis [34].  They have also been shown to inhibit lipoxygenase and
cyclooxygenase activities thus inhibiting cell proliferation [35].  Green tea may also play
a role in inducing apoptosis [36], and recently it has been shown to inhibit angiogenesis
by inhibiting the growth of endothelial cells [37].  In other in vivo experiments,
papilloma-bearing mice were given green tea as their sole source of drinking fluid and/or
they were injected with the green tea polyphenols three times per week.  The green tea
inhibited the growth of the established papillomas, and some tumors were shown to
regress [38].  Other studies have shown that oral administration of green tea inhibits the
progression of papillomas to carcinomas [39], and inhibits lung tumorigenesis [40].
Inhibition of carcinogenesis by green tea polyphenols has also been demonstrated in
many other models including esophagus, stomach, liver, duodenal, small intestine,
pancreas, colon, bladder, prostate and mammary gland cancers [41].  Due to the wide
spread popularity of green tea consumption it could prove to be a tremendous asset in
chemoprevention.
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Curcumin
Curcumin, an extract of tumeric, comes from the rhizome of the Curcuma longa
Linn plant.  This plant is primarily cultivated in South-eastern Asia.  At maturity the
rhizome, or root, is harvested, dried, and ground into powder.  Commercially available
curcumin contains 77% curcumin, 17% demethoxycurcumin, and 3%
bisdemethoxycurcumin (the latter two being considered curcuminoids) [42].  It has been
considered a traditional medicine and used for centuries to treat inflammatory diseases
[43].  In addition, it is also known to possess strong antioxidant activities [44].  The use
of curcumin dates back as early as the 7th century AD in traditional Chinese medicine.  It
was used to treat fever, diarrhea, bronchitis, parasitic worms, leprosy, and kidney and
bladder inflammation.  It has also been mixed with hot water to be used as a cold
remedy.  Some herbalists have suggested inhalation of burning curcumin fumes to
relieve coughs, and topical applications to bruises, eye infections, leech bites, and other
skin infections or conditions.  Recent reports found that it also holds anti-carcinogenic
actions [45,46].  It has been shown to inhibit skin tumors in mice [47], forestomach,
duodenal, and colon cancers in mice [48], and reduce tumor incidence in radiation-
induced tumor initiation in rat mammary gland [49].  Curcumin was found to inhibit cell
progression in normal, dysplastic, and malignant human oral epithelial cell lines [50].  It
is effective against both the initiation and promotion stages of carcinogenesis [45,47,51].
The mechanisms of this compound are not completely understood.  There have been
many publications verifying different mechanisms curcumin uses to inhibit
tumorigenesis.  When applied topically to mouse skin it inhibits B[a]P-DNA adduct
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formation, therefore inhibiting initiation [45].  In in vitro studies using human oral
squamous cell carcinoma cells, curcumin inhibits the activation of cytochrome P-450, a
primary carcinogen-activating enzyme necessary for B[a]P metabolism, thus preventing
B[a]P metabolism and preventing initiation [52].  Curcumin has also been reported to
inhibit DNA adduct formation [53].  Anti-promotional effects include its ability to
inhibit cyclooxygenase and lipoxygenase activities therefore inhibiting cell proliferation
[54].  It has also been reported to enhance apoptosis [55].  Curcumin has been shown to
inhibit the activation of NF-κB, a transcription factor that when activated induces
inflammation and cellular adhesion molecules necessary for invasion and metastasis
[56].  Western medicine has recently taken a great interest in curcumin and its anti-
carcinogenic activities.  Much research has been done and much more is needed to
determine mechanisms of action used by this popular compound.  Due to its extreme
popularity and wide use throughout the world as a spice, a food preservative, and a
coloring agent for foods and drugs, it could prove to be a valuable, inexpensive, and
easily accessible chemopreventive agent for oral cancer.
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MATERIALS AND METHODS
Chemicals
Curcumin, Benzo[a]Pyrene, Mineral Oil, and 5-bromo-2-deoxyuridine (Brdu)
were all purchased from Sigma-Aldrich Company (St. Louis, MO, USA). Green Tea
Polyphenols was obtained from LKT Laboratories, Inc. (St. Paul, MN, USA).
Animal Treatment
50 4-5 week old male Syrian hamsters were purchased from Harlan Sprague
Dawley (Indianapolis, IN, USA).  The animals were housed four per cage in climate-
controlled quarters (55% ±5 humidity, 72OF±2, and spring cycle with 14 hours of light
and 10 hours of dark) with woodchip bedding.  They were provided food and water ad
libitum.  The animals were quarantined for three weeks and tested for hamster viruses
and parasites.  Following the three weeks of quarantine each animal began treatments
with the appropriate chemopreventive compound suspended in mineral oil followed
thirty minutes later by 2.0% B[a]P also suspended in mineral oil.  The right cheek pouch
of each hamster was painted topically with the compounds using a camel hair
paintbrush.  Animals were treated three times per week for eight weeks.  At the end of
eight weeks the animals were injected intraperitoneally with BrdU at a dose of 50mg/kg
of body weight to identify proliferating cells.  The animals were then sacrificed at 24
hours or 72 hours after the last treatment.
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Tissue Processing and Sectioning
The right cheek pouch of each animal was harvested, grossly analyzed, then
rolled into a ball and placed in 10% neutral buffered formalin.  The samples were fixed
for seven days and then processed.  The processing consisted of one hour in 70%
ethanol, two changes one hour each in 95% ethanol, three changes one hour each in
100% ethanol, two changes one hour each in hemo-de (xylene substitute), and two
changes one hour each in 60o Celsius (low melting point) paraffin.  The spherical
hamster cheek pouches were cut in half and embedded cut side down in low melting
point paraffin.  Ten four-micrometer sections were cut using a rotary microtome.  The
sections were placed on a 45o Celsius waterbath to remove wrinkles and then picked up
onto poly-L-lysine (PLL) treated slides.  One slide of each sample was put into a 60o
Celsius oven for twenty minutes to adhere the tissue to the slides, and then stained with
hematoxylin and eosin for further histological evaluation.
Immunohistochemistry
Anti-Brdu:  Four-micrometer sections on PLL slides were placed into a 60o
Celsius oven for twenty minutes to adhere the tissue to the slides.  Once cooled the slides
were deparaffinized and rehydrated by submerging slides into two changes of hemo-de
for five minutes each, two changes of 100% ethanol for five minutes each, one change of
95% ethanol for five minutes, then into distilled water for five minutes.  The slides were
put into 3% hydrogen peroxide from Sigma-Aldrich Company in distilled water for
fifteen minutes to block endogenous peroxidase then washed three times five minutes
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each in Dulbecco’s phosphate buffered saline (PBS) from Sigma-Aldrich Company
containing 1% bovine serum albumin from Roche Diagnostic Corporation (Indianapolis,
IN, USA).  They were then put into 1N hydrochloric acid from Fisher Scientific (Fair
Lawn, NJ, USA) at 37o Celsius for 20 minutes.  Slides were washed as previously
described.  Slides were then incubated in 0.5% protease XXIV from Sigma-Aldrich
Company for fifteen minutes then washed.  Slides were incubated in 10% normal horse
serum from Gibco BRL (Grand Island, NY, USA) in PBS for 30 minutes to block non-
specific staining then, without washing, were incubated in mouse monoclonal Anti-Brdu
from Becton Dickinson Immunocytometry Systems (San Jose, CA, USA) at 1:150 for
one hour at room temperature.  The slides were then washed and incubated in
Biotinylated Anti-Mouse IgG from Vector Laboratories (Burlingame, CA, USA) at
1:200 for thirty minutes at room temperature.  The slides were washed and incubated in
Avidin-Biotin Complex from Vector Laboratories for thirty minutes at room
temperature.  The slides were washed and developed with 3,3’-Diaminobenzidine
(DAB) from Sigma-Aldrich Company.  They were rinsed in distilled water and
counterstained in Gill 1 hematoxylin from ThermoShandon (Pittsburgh, PA, USA) for
one minute, rinsed in distilled water, air-dried and coverslipped with a synthetic resin
permanent mounting medium Consul Mount also from ThermoShandon.
TUNEL:  Four-micrometer sections on PLL slides were placed into a 60o Celsius
oven for twenty minutes to adhere the tissue to the slides.  Once cooled the slides were
deparaffinized and rehydrated by submerging slides into two changes of hemo-de for
five minutes each, two changes of 100% ethanol for five minutes each, one change of
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95% ethanol for five minutes, then into distilled water for five minutes.  The ApopTag
Peroxidase In Situ Apoptosis Detection Kit from Serologicals Corporation (Norcross,
GA, USA) was used for this assay.  The slides were incubated in 5mg/ml proteinase K
from Sigma-Aldrich Company for ten minutes and then washed in PBS.  They were then
put into 3% hydrogen peroxide in PBS for five minutes to block endogenous peroxidase.
The slides were washed in PBS and incubated in the kit-provided equilibration buffer for
no longer than thirty minutes at room temperature.  The kit-provided TdT enzyme was
mixed with the reaction buffer at 1:100 and incubated on the slides for one hour at 37o
Celsius.  The slides were washed with the kit-provided stop-wash buffer diluted in
distilled water for fifteen minutes at room temperature.  They were then washed and
incubated in the kit-provided anti-digoxigenin peroxidase conjugate for 30 minutes at
room temperature.  The slides were washed, DAB was used to develop, and Gill 1
hematoxylin was used as the counterstain.  The slides were then washed in distilled
water, air dried, and coverslipped using synthetic resin for the permanent mounting
medium.
Anti-P53: Four-micrometer sections on PLL slides were placed into a 60o Celsius
oven for twenty minutes to adhere the tissue to the slides.  Once cooled the slides were
deparaffinized and rehydrated by submerging slides into two changes of hemo-de for
five minutes each, two changes of 100% ethanol for five minutes each, one change of
95% ethanol for five minutes, then into distilled water for five minutes.  The slides were
put into 3% hydrogen peroxide in distilled water for fifteen minutes to block endogenous
peroxidase and washed three times five minutes each in PBS containing 1% bovine
22
serum albumin.  They were then boiled for fifteen minutes in 10mM citrate buffer 6.0
pH  for antigen retrieval.  After the slides cooled they were washed and incubated in
10% normal horse serum from Gibco BRL in PBS for 30 minutes to block non-specific
staining, then without washing, were incubated in monoclonal Anti-p53 from Vector
Laboratories at 1:100 overnight at 4O Celsius.  The slides were then washed and
incubated in Biotinylated Anti-Mouse IgG at 1:200 for thirty minutes at room
temperature.  The slides were washed and incubated in Avidin-Biotin Complex for thirty
minutes at room temperature.  The slides were washed and developed with DAB.  They
were rinsed in distilled water and counterstained in Gill 1 hematoxylin for one minute,
rinsed in distilled water, air-dried and coverslipped with a synthetic resin permanent
mounting medium.
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RESULTS
This short-term experiment was completed to determine if green tea and
curcumin show any chemopreventive effects against B[a]P- induced oral carcinogenesis
in the hamster cheek pouch using short-term mechanistic markers.  Table III shows the
division of the treatment groups, the number of animals per group, the average weights
at the beginning of the experiment, the average weights at the end of the experiment, and
the average daily gain.
    Table III.  Treatment groups and weights.  Short-term experiment treatment
    groups, number of animals, average weights, and average weight gains.
Group Treatment Numberof
Animals
Week 1
Average
Weight
(grams)
Week 8
Average
Weight
(grams)
Average
Daily Gain
(grams)
I Mineral Oil 8 110.6 120.7 0.180
II 2.0% B[a]P 8 108.3 116.8 0.152
III 2.5%Green Tea 8 135.5 145.5 0.179
IV 5.0%Green Tea 8 140 154.9 0.266
V 0.6%Curcumin 8 123.3 131.4 0.145
VI 6.0%Curcumin 8 137.3 146.5 0.164
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At 7-8 weeks of age treatment began on all animals.  All compounds were
suspended in mineral oil.  Only the right cheek pouch of each animal was treated
topically using a paintbrush.  Previous experiments in our lab determined that each dip
of the paintbrush into the viscous mineral oil yielded approximately 200µl per
application.  Group I was treated one time per treatment with mineral oil, three
treatments per week for eight weeks.  Group II was treated one time per treatment with
2.0% B[a]P, three treatments per week for eight weeks.  Group III was treated with 2.5%
green tea polyphenols followed thirty minutes later by 2.0% B[a]P per treatment, three
treatments per week for eight weeks.  Group IV was treated with 5.0% green tea
polyphenols followed thirty minutes later by 2.0% B[a]P per treatment, three treatments
per week for eight weeks.  Group V was treated with 0.6% curcumin followed thirty
minutes later by 2.0% B[a]P per treatment, three treatments per week for eight weeks.
Group VI was treated with 6.0% curcumin followed thirty minutes later by 2.0% B[a]P
per treatment, three treatments per week for eight weeks.
At the end of the eighth week treatment was halted and animals were sacrificed.
Half of the animals from each group were sacrificed 24 hours after the last treatment.
This would allow us to look at the more acute cellular activities of the cheek pouch.  The
remaining half of the animals were sacrificed 72 hours after the last treatment to
examine the more chronic cellular activities of the cheek pouch.
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Histopathology
The first parameter analyzed was gross appearance at time of sacrifice.  Results
are illustrated in Table IV.  All Group I negative control hamsters treated with mineral
oil appeared to have normal pouches.  The pouches were pink in color and showed no
signs of irritation.  Of the positive control Group II treated with 2% B[a]P suspended in
mineral oil 75% of the animals had red, congested pouches while 25% of the pouches
appeared normal.  Of the experimental Group III animals treated with 2.5% green tea
polyphenols + 2.0% B[a]P, 50% of them had red, congested pouches while the
remaining 50% appeared normal.  Of experimental Group IV animals treated with 5.0%
green tea polyphenols + 2.0% B[a]P, 75% had only minor redness and irritation and 25%
appeared normal.  Of experimental Group V animals treated with 0.6% curcumin + 2.0%
B[a]P, 100% of the animals appeared normal.  Of experimental Group VI animals
treated with 6.0% curcumin + 2.0% B[a]P 10% of the pouches had minor redness or
irritation, and 90% of the pouches looked normal.  The pouches were then fixed,
processed, sectioned, and stained with hematoxylin and eosin (H&E).  Using the H&E
slides we were able to analyze the histology of each pouch and determine the presence of
inflammation, hyperplasia, hyperkeratosis, dermis thickening, and/or congestion.  Figure
7 demonstrates the epithelium of a normal pouch visualizing a thin layer of keratin at the
surface.  Just below the keratin layer are two to three layers of differentiating cells.
Next, is a single layer of basal cells or proliferating cells.  The dermis consists of loose
fibrous connective tissue, and just below is a layer of muscle.  Figure 8 is a typical pouch
treated with 2% B[a]P having hyperkeratosis in the keratin layer, increased hyperplasia
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in the differentiating cell layers (four to five layers of differentiating cells), and
hyperplasia in the basal layer.  The connective tissue of the lamina propria is more dense
than normal, and the blood vessels appeared to be congested.  The experimental groups
showed slight hyperkeratosis and only minor hyperplasia and the dermis was normal.
   Table IV.  Gross appearance evaluation.  Evaluation of gross appearance of the
   hamster cheek pouch.
Group Treatment Normal
Appearance
% with mild
irritation
% with severe
irritation
I MO 100% ---- ----
II B[a]P 25% ---- 75%
III 2.5% GreenTea 50% ---- 50%
IV 5.0% GreenTea 25% 75% ----
V 0.6% Curcumin 100% ---- ----
VI 6.0% Curcumin 90% 10% ----
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                             Figure 7.  Histology of normal cheek pouch.
     Figure 8.  Histopathology of B[a]P cheek pouch.
     Histopathology of hamster cheek pouch treated with
        2% B[a]P for 8 weeks.
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BrdU Immunohistochemistry
Next step was to quantify cellular proliferation in the cheek pouches of the
normal and experimental hamsters.  Because cancer is associated with an increase in
proliferation and/or a decrease in cell death losing the homeostatic balance between cell
proliferation and cell death, determining proliferation rate is one of the most important
biomarkers in cancer research.  Before sacrificing the animals they were injected with
Brdu, a DNA precursor that incorporates into the DNA of the cells cycling through the
S-phase of the cell cycle.
These proliferating cells were detected by immunohistochemistry using an anti-
Brdu antibody.  The rate of proliferation was determined by counting a total of 600 basal
cells in randomly selected fields.  The proliferation index of normal squamous cell
epithelium in the hamster oral mucosa is 5-8%.  The rate of proliferation in the control
pouches treated with mineral oil and sacrificed 24 hours after the last treatment was
11%.  This was anticipated due to the acute irritation of the treatments.  Expectedly, at
the 72-hour sacrifice the rate of proliferation was back down to 8%.  The proliferation
rate at the 24-hour sacrifice in the positive control group treated with B[a]P was very
high at 38%, and at the 72-hour sacrifice decreased to 14%.  Figure 9 graphs out the
experimental groups of green tea polyphenols compared with the control groups.
Comparing the 24-hour groups with the positive control group we see a statistically
significant decrease in proliferation in the two extreme doses of green tea, while the 72-
hour results had only a slight increase in proliferation.  Table V shows the percent
inhibition of proliferation in each dose of green tea polyphenols.  At the 24-hour time-
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point the 2.5% green tea polyphenols had a 43.6% inhibition and the 5.0% green tea
polyphenols had a 29.2% inhibition.  There was no inhibition in the 72-hour time-point.
Figure 10 graphs the groups treated with curcumin.  Of these two doses the lesser dose
significantly decreased the number of proliferating cells when compared to the positive
control group.  The greater dose of curcumin showed a slight decrease.  At the 72-hour
sacrifice only the lesser dose, 0.6% curcumin had a statistically significant decrease in
proliferation.  Table VI shows the percent inhibition of proliferation in each dose of
curcumin.  At the 24-hour time-point the 0.6% curcumin had 33.1% inhibition while the
6.0% curcumin had only an 8.6% inhibition.  At 72-hours only the 0.6% dose had
inhibition and it was a 52.4% inhibition.
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Figure 9.  Green tea BrdU incorporation.  BrdU incorporation in green tea
treated cheek pouches.  Represented are the group averages of percent
positive cells per 600 cells counted from random fields.
         Table V.  Green tea proliferation inhibition.  Percent proliferation inhibition on
         green tea treated pouches.
24 Hour 72 Hour
2.5% Green Tea 43.6% < 0%
5.0% Green Tea 29.2% < 0%
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Figure 10.  Curcumin BrdU incorporation.  BrdU incorporation in curcumin
treated cheek pouches.  Represented are the group averages of percent
positive cells per 600 cells counted from random fields.
         Table VI.  Curcumin proliferation inhibition.  Percent proliferation inhibition in
         curcumin treated pouches.
24 Hour 72 Hour
0.6% Curcumin 33.1% 52.4%
6.0% Curcumin 8.6% < 0%
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P53 Immunohistochemistry
The P53 gene has been considered the “guardian of the genome” by many
researchers.  It is considered to be a checkpoint factor, or an “emergency brake” in the
cell cycle.  It prevents damaged genetic information from being passed from generation
to generation.  It plays a major role in the transcription of DNA, in numerous metabolic
processes and in cell growth and proliferation.  When a mutation occurs in the p53 gene
it loses its ability to block the abnormal cells from growing.  P53 protein is in the
nucleus, and if the DNA is damaged the protein concentration increases dramatically.
High levels of p53 are an indication of possible DNA damage and usually will lead to
cell cycle arrest or apoptosis.  The loss of p53 function is found in many human and
experimental cancers.  Alterations in the p53 gene lead to genetic instability and
excessive cellular growth [57].  The possible dysfunction or activation of p53 gene can
be visualized by immunohistochemistry as an accumulation of p53 protein.  It has been
determined that p53 protein accumulation in the hamster cheek pouch carcinogenesis
model is similar to that of human oral lesions, and is expressed in early phases of
tumorigenesis [58].
The cellular accumulation of p53 protein was labeled using an anti-p53 antibody.
The percent positive cells were calculated per 1000 cells.  In the negative control groups,
24-hour and 72-hour, there was no expression of p53 protein accumulation.  At the 24-
hour sacrifice, the B[a]P treated group showed 15% of the cells positive for p53 protein
accumulation.  Figure 11 graphs the results of the green tea polyphenol treated pouches.
The lesser dose, 2.5% green tea polyphenol was the only experimental group that had a
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statistically significant decrease in p53 protein accumulation at the 24-hour sacrifice
when compared to the positive control group.  The 72-hour sacrifice showed no
significant effect.  Table VII shows the percent inhibition of p53 protein accumulation in
each dose.  At 24-hours the 2.5% green tea polyphenols had a 58.5% inhibition and the
5.0% green tea polyphenols had a 33.3% inhibition.  At the 72-hour time-point only the
5.0% dose had inhibition and it was only a 20% inhibition.  Figure 12 graphs the results
of the curcumin treated pouches.  At 24-hours both doses did have a lesser amount of
p53 protein accumulation compared to the positive control group, however, these results
were not statistically significant.  Table VIII shows the percent inhibition of p53 protein
accumulation in each dose.   At the 24-hour time-point the 0.6% curcumin had a 49%
inhibition and the 6.0% curcumin had a 21.1% inhibition.  The 72-hour time-point had
no inhibition of p53 protein accumulation.
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        Figure 11.  Green tea p53 protein accumulation.  P53 protein accumulation
        in green tea treated cheek pouches.  Represented are the group averages of
        percent positive cells per 1000 cells counted from random fields.
     Table VII.  Green tea p53 protein inhibition.  Percent p53 protein accumulation
     inhibition in green tea treated pouches.
24 Hour 72 Hour
2.5% Green Tea 58.5% < 0%
5.0% Green Tea 33.3% 20.0%
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Figure 12.  Curcumin p53 protein accumulation.  P53 protein accumulation
in curcumin treated cheek pouches.  Represented are the group averages of
percent positive cells per 1000 cells counted from random fields.
         Table VIII.  Curcumin p53 protein inhibition.  Percent p53 protein accumulation
         inhibition in Curcumin treated pouches.
24 Hour 72 Hour
0.6% Curcumin 49.0% < 0%
6.0% Curcumin 21.1% < 0%
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Apoptosis Detection
Apoptosis is programmed cell death.  It is also referred to as cellular suicide.  It
is a natural way for tissues to maintain homeostasis and to eliminate genetically
damaged cells.  Histologically, these cells shrink, the chromatin begins to degrade, the
mitochondria break down and the cell breaks into small membrane-wrapped fragments
to be phagocytized by macrophages and dendritic cells.  Both curcumin and green tea are
known inducers of apoptosis, although the exact mechanisms remain an enigma.
To detect the apoptotic cells we used the TdT-mediated X-dUTP nick end
labeling (TUNEL) assay.  Terminal deoxynucleotidyl transferase (TdT) is used to label
double-stranded DNA breaks.  The label is then detected with an anti-Digoxigenin and
visualized with DAB.  At the 24-hour sacrifice, the negative control group had
approximately 2 apoptotic cells per 5 centimeters of epithelium, and the positive control
group had approximately 5 apoptotic cells per 5 centimeters of epithelium.  All of the
experimental groups had only 4 to 6 apoptotic cells per 5 centimeters of epithelium, but
neither group was statistically significant.  However, the 72-hour sacrifice showed an
increase in apoptosis in a dose dependent manner in both green tea polyphenols and
curcumin.  Figure 13 graphs the green tea polyphenol induced apoptosis showing a
significant increase in the higher dose when compared to the negative control group.
Figure 14 graphs curcumin-induced apoptosis showing a large increase, however, it was
not stastically significant.
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Figure 13.  Green tea apoptosis activity.  Apoptosis detection in green tea
treated cheek pouches.  Represented are the group averages of number of
positive cells per five centimeters of epithelium.
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Figure 14.  Curcumin apoptosis activity.  Apoptosis detection in curcumin
treated cheek pouches.  Represented are the group averages of number of
positive cells per five centimeters of epithelium.
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DISCUSSION AND CONCLUSION
The present study, using short-term mechanistic markers, indicates that curcumin
and green tea polyphenols may have plausible inhibitory effects on B[a]P-induced
carcinogenesis in the hamster cheek pouch.  Recent research has taken a great interest in
environmental carcinogens.  Many of the known carcinogens may be found in our air,
soil, water, and food supplies. In particular, the environmental carcinogen, B[a]P [22],
has been a contributor to cancers of respiratory and digestive origins [59-64].  Ruiz
summarized that the epidemiologic evidence has shown an increased risk of oral cancer
upon chronic consumption of alcohol and tobacco products [7], Weyand discussed both
the induction of lung tumors and forestomach tumors by the ingestion of manufactured
gas plant residues and B[a]P, respectively [59], and Rubin reviewed possible
mechanisms of lung carcinogenesis in mice by inhalation of environmental tobacco
smoke [64].
Curcumin and green tea polyphenols have been studies for centuries.  They are
well known for their antioxidant and anti-inflammatory activities and in more recent
years for their anti-carcinogenic activities.  Huang reviewed that topical treatment of
curcumin inhibits B[a]P and DMBA initiation, TPA-induced tumor promotion, and
epidermal cell proliferation.  Administered through the diet of mice, curcumin reduced
the number and the size of tumors, and inhibited duodenal tumors and colon tumors [65].
Green tea polyphenols administered orally have been shown to inhibit the growth of
established papillomas, regress some papillomas [38] and inhibit papilloma progression
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into carcinomas [39].  Mechanistically they inhibit DNA damage by scavenging reactive
oxygen species [66], they prevent DNA adducts, therefore preventing initiation [34], and
inhibit cell proliferation by inhibiting lipoxygenase and cyclooxygenase activities [35].
Because chemoprevention studies are often long and expensive, the use of early
biomarkers could serve as valuable indicators in determining possible chemopreventive
compounds by functioning as intermediate endpoints.  Important early biomarkers
include, but are not limited to, proliferation markers, P53 protein expression, and
apoptosis detection.  Previous data has shown that both green tea and curcumin may
inhibit promotion [35,54] and initiation[34,53].  Promotion is vital stage of
carcinogenesis where increased proliferation can allow the selection of mutated cells.
This increased proliferation is often a precursor to carcinogenesis.  Another early marker
is P53 protein accumulation which often indicates possible p53 gene alterations [58], and
high levels of apoptotic activity could indicate that the mutated cells are not being
allowed to progress through the cell cycle and proliferate.  The short-term biomarkers
used in this experiment have determined that both green tea polyphenols and curcumin
significantly inhibited carcinogen-induced proliferation, decreased the amount of cells
expressing p53 protein, and induced apoptosis.  Using these short-term mechanistic
markers, our data has suggested that both green tea polyphenols and curcumin may have
an inhibitory effect on B[a]P-induced carcinogenesis in the hamster cheek pouch.  These
results could suggest that these compounds may inhibit cell proliferation, a promotional
effect, and/or prevent initiation by preventing DNA damage by blocking carcinogen
metabolism and DNA adduct formation, or preventing genetic mutations. These results
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do not prove that these compounds will inhibit the production of squamous cell
carcinomas in our model, however, they do indicate that they may have a plausible
chemopreventive effect.
It will be of great interest and importance to continue with long-term experiments
to determine whether or not these compounds will actually inhibit the formation and
progression of squamous cells carcinomas in the oral mucosa.  It is also important to
determine the mechanisms of action these compounds may use to carry out their
chemopreventive effects.  It is believed that they can inhibit both initiation and
promotion of cells, reminding us of the complexity of these compounds and their
possible mechanisms of actions.  If research can recognize and prove the valuable effects
of natural anti-carcinogenic compounds such as green tea and curcumin, particularly
those that are commonly used throughout the world, there is possibility they can be used
as beneficial tools against cancer simply by manipulating dietary intake to prevent
carcinogen initiation or further progression into life threatening diseases.
Chemoprevention is an important tactic in the fight against cancer, and could eventually
lead to lower incidence rates, improve prognosis, and reduce mortality rates.
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